300 related articles for article (PubMed ID: 30226561)
1. Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma.
Wang D; Wang R; Huang A; Fang Z; Wang K; He M; Xia JT; Li W
Oncol Rep; 2018 Nov; 40(5):2628-2636. PubMed ID: 30226561
[TBL] [Abstract][Full Text] [Related]
2. Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.
Funamizu N; Hu C; Lacy C; Schetter A; Zhang G; He P; Gaedcke J; Ghadimi MB; Ried T; Yfantis HG; Lee DH; Subleski J; Chan T; Weiss JM; Back TC; Yanaga K; Hanna N; Alexander HR; Maitra A; Hussain SP
Int J Cancer; 2013 Feb; 132(4):785-94. PubMed ID: 22821831
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
Wang SS; Zheng M; Pang X; Zhang M; Yu XH; Wu JB; Gao XL; Wu JS; Yang X; Tang YJ; Tang YL; Liang XH
Mol Carcinog; 2019 Oct; 58(10):1809-1821. PubMed ID: 31219646
[TBL] [Abstract][Full Text] [Related]
4. A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.
Yang S; He P; Wang J; Schetter A; Tang W; Funamizu N; Yanaga K; Uwagawa T; Satoskar AR; Gaedcke J; Bernhardt M; Ghadimi BM; Gaida MM; Bergmann F; Werner J; Ried T; Hanna N; Alexander HR; Hussain SP
Cancer Res; 2016 Jul; 76(13):3838-50. PubMed ID: 27197190
[TBL] [Abstract][Full Text] [Related]
5. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
6. PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells.
Dai H; Shen K; Yang Y; Su X; Luo Y; Jiang Y; Shuai L; Zheng P; Chen Z; Bie P
Cell Death Dis; 2019 Aug; 10(8):595. PubMed ID: 31395860
[TBL] [Abstract][Full Text] [Related]
7. Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.
Subbannayya T; Leal-Rojas P; Barbhuiya MA; Raja R; Renuse S; Sathe G; Pinto SM; Syed N; Nanjappa V; Patil AH; Garcia P; Sahasrabuddhe NA; Nair B; Guerrero-Preston R; Navani S; Tiwari PK; Santosh V; Sidransky D; Prasad TS; Gowda H; Roa JC; Pandey A; Chatterjee A
BMC Cancer; 2015 Nov; 15():843. PubMed ID: 26530123
[TBL] [Abstract][Full Text] [Related]
8. Macrophage immigration inhibitory factor promotes cell proliferation and inhibits apoptosis of cervical adenocarcinoma.
Guo P; Wang J; Liu J; Xia M; Li W; He M
Tumour Biol; 2015 Jul; 36(7):5095-102. PubMed ID: 25716200
[TBL] [Abstract][Full Text] [Related]
9. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
Yuan Q; Zhang Y; Feng L; Jiang Y
J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
[TBL] [Abstract][Full Text] [Related]
10. D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth.
Guo D; Guo J; Yao J; Jiang K; Hu J; Wang B; Liu H; Lin L; Sun W; Jiang X
Int J Cancer; 2016 Nov; 139(9):2056-67. PubMed ID: 27434219
[TBL] [Abstract][Full Text] [Related]
11. ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis.
Gao X; Jiang M; Chu Y; Han Y; Jin Y; Zhang W; Wang W; Yang S; Li W; Fan A; Cao J; Wang J; Liu H; Fu X; Chen D; Nie Y; Fan D
Cancer Lett; 2022 Jan; 524():42-56. PubMed ID: 34582976
[TBL] [Abstract][Full Text] [Related]
12. Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC).
Li Z; Lin P; Gao C; Peng C; Liu S; Gao H; Wang B; Wang J; Niu J; Niu W
Tumour Biol; 2016 Apr; 37(4):5117-31. PubMed ID: 26547582
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia induces oncogene yes-associated protein 1 nuclear translocation to promote pancreatic ductal adenocarcinoma invasion via epithelial-mesenchymal transition.
Wei H; Xu Z; Liu F; Wang F; Wang X; Sun X; Li J
Tumour Biol; 2017 May; 39(5):1010428317691684. PubMed ID: 28475017
[TBL] [Abstract][Full Text] [Related]
15. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
[TBL] [Abstract][Full Text] [Related]
16. ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells.
Fukushima H; Yasumoto M; Ogasawara S; Akiba J; Kitasato Y; Nakayama M; Naito Y; Ishida Y; Okabe Y; Yasunaga M; Horiuchi H; Sakamoto E; Itadani H; Mizuarai S; Oie S; Yano H
Mol Cancer; 2016 May; 15(1):32. PubMed ID: 27145964
[TBL] [Abstract][Full Text] [Related]
17. MIF confers survival advantage to pancreatic CAFs by suppressing interferon pathway-induced p53-dependent apoptosis.
Suresh V; Dash P; Suklabaidya S; Murmu KC; Sasmal PK; Jogdand GM; Parida D; Sethi M; Das B; Mohapatra D; Saha S; Prasad P; Satoskar A; Senapati S
FASEB J; 2022 Aug; 36(8):e22449. PubMed ID: 35839070
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
[TBL] [Abstract][Full Text] [Related]
19. High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).
Gong C; Zhang Y; Chen Y; Zhang H; Liu X; Xue H; Ji L; Wang L; Yang L; Zhou G; Wan C
Tumour Biol; 2015 Dec; 36(12):9189-99. PubMed ID: 26088450
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3β.
Liu RM; Sun DN; Jiao YL; Wang P; Zhang J; Wang M; Ma J; Sun M; Gu BL; Chen P; Liu K; Ma H; Gao SG; Ma YF; Qi YJ
Cancer Lett; 2018 Jan; 412():289-296. PubMed ID: 29079416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
